Skip Navigation

Rheumatology 2004 43(11):1447-1448; doi:10.1093/rheumatology/keh348
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rajakulendran, S.
Right arrow Articles by Deighton, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajakulendran, S.
Right arrow Articles by Deighton, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 43 No. 11 © British Society for Rheumatology 2004; all rights reserved

LETTER TO THE EDITOR

Do guidelines for the prescribing and monitoring of leflunomide need to be modified?

S. Rajakulendran and C. Deighton

Department of Rheumatology, Derby Royal Infirmary

Correspondence to: Dr. C. Deighton, Department of Rheumatology, London Rd, Derby, DE1 2QY. Email: chris.deighton@sdah-tr.trent.nhs.uk

The first 10% of the full text of this article appears below.

SIR, Leflunomide is the newest of the non-biological disease-modifying anti-rheumatic drugs (DMARDs), having been licensed for use in the UK 3 years ago. As rheumatologists incorporate leflunomide into their clinical practice, it is evident that there is variation amongst clinicians in the place of the drug in their practice, and in the initiation regime and monitoring of the drug. We conducted a survey amongst rheumatologists on the Midlands Rheumatology Society mailing list to evaluate the current prescribing practice with leflunomide. The results of the survey were compared with the recommendations in the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?